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Medical-grade Ultra-high Molecular Weight Polyethylene: 
Past, Current, and  Future. 
 
Ultra-high molecular weight polyethylene is a semi-crystalline polymer (45%-
60%) with six decades of orthopaedic applications. This polymer has a high 
fracture toughness (30 kJ/m2) which comes from the molecular weight and the 
chain entanglements. Adverse alteration of the properties may lead to the part's 
pre-mature failure.  This paper reviews the current manufacturing methods, and 
their effect on the properties of the polymer. The review also focused on the 
attempts of enhancing the polymer properties. The main cause of failure is 
implant loosing due to the polymeric wear particles. Many manufacturers have 
attempted to enhance the wear and oxidation properties of the polymer, the 
outcome of the new technologies is critically reviewed. Finally, the review 
explores the potential for future developments.  
 
Keywords: Ultra-high molecular weight polyethylene; Vitamin E; Radiopaque; 
Packaging; Sterilisation; Crystallinity; Cross-linking. 
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Introduction 
Ultra-high Molecular weight polyethylene (UHMWPE) has a low friction, high 
resistance to wear, high toughness [1] and the polymer is bio-inert. Information with 
regards to the polymer wear and friction behaviour are summarised in Table 1. The 
linear wear rate of the acetabular cup is about 0.2 mm/year and the friction coefficient 
of the polymer is lower than the other commonly used polymer such as poly amides, 
polytetrafluoroethylene and poly esters, polyether ether ketone (ranged between 0.25-
0.6, against steel, dry condition) [2]. In average the friction coefficient of 
UHWMPE/metal is half of the PEAK/metal. Therefore, UHMWPE is an ideal material 
to use for long-term implants. However, many retrieval studies have shown evidence of 
severe oxidation and wear in UHMWPE implants. Oxidative stability and properties of 
UHMWPE are linked to the chemical structure, molecular weight, crystalline 
organization, and thermal history of the polymer [3]. It is crucial that any changes made 
to UHMWPE implants, do not detrimentally affect their wear properties, oxidation 
resistance or fatigue strength.  
 
Table 1. Physical and mechanical properties of UHMWPE(GUR 1050) 
 
From 2003 to 2016 About 796,636 total hip, 871,472 knee are implanted in 
England and Wales and the most common articulation used was polyethylene [4]. With 
the ageing population, it is crucial to improve the longevity of the parts. Despite the 
successful clinical outcome of the most orthopaedic replacement; the longevity of the 
prosthesis is limited to approximately 15 years [5], and any modification can jeopardize 
the longevity of the part. Researchers are always trying to enhance the polymer 
properties and there have been a significant new developments in this field. This review 
attempts to cover the new technologies. As the polymer changes the body might react to 
the new polymer differently which needs to be understood to imply the alteration in the 
implant design. The current data regarding on the mechanical and material properties of 
the polymer, method of manufacturing, sterilisation and packaging of UHMWPE 
components, as well as examining common mechanisms of failures, new technologies 
as vitamin E UHMWPE and contemplating the future of the polymer.  
Clinical Uses of UHMWPE 
            This polymer was introduced clinically in November 1962 as an articulating 
surface for hip replacement implants and in the late 1960s, it was first used for knee 
replacement [6,7]. In a total knee arthroplasty, UHMWPE provides articulating surfaces 
between the femur and tibia as well as between the femur and the patella [7]. Depending 
on the pathology of the disease, surgeons might prefer to use unicondylar knee 
arthroplasty [7]. There are 300 different designs of knee prostheses available around the 
world, and UHMWPE is used as the bearing materials in almost all of them [7]. 
           The bearings are also used in other types of orthopaedic joints including 
shoulder, ankle and elbow replacement [8–11]. Although these procedures are 
performed much less frequently than hip and knee replacements [12],  the performance 
of these prostheses also rely on the polymer for motion and load bearing [8–11]. 
UHMWPE is also be used in finger joint replacement [13]. The surgical considerations 
for small joint replacement are different to other joint arthroplasties [14]. In finger joint 
replacement the implant acts as an internal splint allowing the soft tissues to rebalance 
[14]. In some designs of these prostheses, UHMWPE bearings have been used [14,15]. 
UHMWPE has also been used in spinal applications [16]. Chronic back pain can 
be treated by spinal fusion or disc arthroplasty.  In both cases, UHMWPE may play an 
important role. UHMWPE fibre can be used for spinal fusion and UHMWPE bearings 
in disc replacement [17–19]. 
             In the last few years, the polymer has been used for anterior cruciate ligament 
reconstruction [20,21]. In fibre form, it can be used for braided sutures [22]. The 
modulus of polyethylene fibre is as high as 222GPa and the strength of the fibre is 8GPa 
[23]. Porous polyethylene (pore diameter between 100-250µm) can be used for facial 
reconstruction [24]  and bone defect replacement [25–27]. Porous PE (Medpor®) 
(Medpor Biomaterial; Porex Surgical, Newman, GA) has an application in craniofacial 
reconstruction [25,28,29], because it can closely mimic porous cancellous bone tissue 
[26]. This type of polyethylene has the same hardness as cancellous bone tissue and it 
can be trimmed and modified during the surgery. The polymer makes up 54% volume 
of the implant and rest of the implant are filled with air. The pores structure allows the 
bone to ingrowth through the implant with collagen deposition. Therefore, the implant 
is resistance to infection. Porous polyethylene is able to deform by surrounding tissue 
[29]. The tensile strength of porous polyethylene is as highs as 4.1GPa, hence polymer 
is able to resist stress and fatigue [30].   
 
 
 Resin Manufacturing 
The formation of resin is the first step toward the manufacturing of an 
UHMWPE component. The resin can be polymerised by the Ziegler-Natta process 
using ethylene and hydrogen gases and titanium tetra-chloride (a catalyst) [31]. A 
solvent is required for heat and mass transfer [31]. The polymerisation of the resin 
requires a specialised production plant capable of handling dangerous chemicals. 
Hence, there are only two companies capable of making resins. Medical grade 
UHMWPE is free of calcium stearate and has a higher purity requirement as set by ISO 
5834-1 [32]. 
 Type 1 and 2 resins (GUR 1050, GUR 1020) are produced by a German 
company called Celanese, and Basell used to produce type 3 resin (1900). Although the 
manufacturing method is identical, a slight variation in the molecular weight of the 
different resins was reported [33]. This variation can be associated with the catalyst 
package and the polymerisation condition. Table 2 summarises the differences between 
the resins. Furthermore, a slight variation between the resin morphology was reported. 
Type 1,2 reins appeared to be more lamellar while type 3 resin has a spherulitic 
morphology.  Type 3 resin is no longer on the market.  
Table 2, Physical properties   of medical grade   UHMWPE resins. 
 
 
The molecular weight of the resin effects on their mechanical properties and 
their wear abrasion resistance. Clinical data showed that 1900 has a superior resistance 
to wear and oxidation but the lowest mechanical properties among the three resins. 
While, as Table  2 the experimental data showed no statistically significant difference 
between the oxidation resistance of the resins [34]. The wear resistance of 1050 is 
slightly better than GUR 1020 while GUR 1020 has a better impact strength and 
toughness. 
 
 
 
 
 
 
Manufacture of UHMWPE Components 
 
The second stage towards making a component is the consolidation of the resin 
under elevated temperature and pressure. Due to its high molecular weight, the polymer 
has a high melt viscosity and it is not able to flow like lower molecule weight 
polyethylene [33]; UHMWPE has zero melt flow index. Hence, ram extrusion and 
compression moulding are two typically used methods to produce semi-finished or 
finished components  [3,33].  
 The machining temperature needs to be closely monitored as the UHMWPE can 
be easily damaged by excessive heat [35]. Figure 1 shows the manufacturing steps. 
Machining is able to change the surface and subsurface properties of the polymer. A 
higher machining speed leads to a greater mechanical degradation and a lower wear 
resistance. However, no significant correlations have been found between the 
machining parameters and the wear coefficient[36,37].  
 The difference between parts made from extrusion and compression is 
insignificant, and in both cases, the mechanical properties exceed the ASTM F648 
requirement} [38]. The main difference between the ram extruded and compression 
moulded parts is in the morphology of the segments [3]. TEM images showed that ram 
extruded polymer lamellae are aligned along the extrusion direction while compression 
moulded samples showed random orientation of the crystalline lamellae. Lack of 
preferred orientation in lamellae enhance the fatigue resistance and crack propagation of 
the polymer which are summarised in table 3. 
 
Table 3Fatigue and crack propagation of ram extruded and compression moulded polymer. Adopted from ref [39]. 
 
Some manufacturers prefer to consolidate the resin into semi-finished parts 
using an individual mould, avoiding intermediate machining steps. Direct compression 
moulding leads to a smooth surface finish with no machining marks [3]. Tensile 
properties of DCM parts are suggested to be higher than other methods [40–42]. This is 
because compression moulding can be performed under a very high pressure (300 
MPa), hence there are few/no fusion defects which leads to up to a 40% increase in the 
yield strength without decreasing the impact strength or toughness of the polymer  
[3,35].  Another possible reason for the better tensile properties is the greater percentage 
of crystallinity of directly moulded parts which is nearly 72% percent.  This can be 
associated with lower risk of oxidation in the component and a better resistance to post-
irradiation ageing. Microscopic images from the surface of the component also support 
that direct compression moulded parts have an ability to resist oxidation. The ultimate 
tensile strength of the samples can drops by 60% over a range of oxidation [39].   
This can be because spatial variations in the degree of consolidation of ram 
extruded the bars along the radius which can be indicated by the presence of inter-
particle regions and fusion defects [39,41].  
A study by Bankston et al, investigated the wear properties of samples 
manufactured using direct compression or another form of machining (either ram 
extrusion or compression moulded part). Clinical studies on two groups of patients, 
assigning 54 patients to each group with no significant difference between in the 
average age, weight (average weight =161 pounds and age =66 years old) for average 
followup of 6.7 years showed the average linear wear rate per year was 0.05 mm for 
direct compression moulding and 0.11 mm for machined polyethylene [43]. Retrieved 
implants show that direct compression moulded samples have a higher chemical 
stability  and little to no oxidative damage and no evidence of delamination or 
discolouration, in retrievals after four years [43–45].  However, the number un-fatigued 
parts dropped sharply as the implantation time increased (32% for moulded components 
and 36% of the machined component) 
Direct Compression Moulded is also capable of producing unique designs, but it 
is a time consuming and expensive method[45].   
 
Figure 1. The processing steps involved in making an UHMWPE part. 
 
Cross-linking 
 
 
The most common failure mechanisms are aseptic loosening and dislocation 
(82% of cases) which are associated with wear resistance of polyethylene. To improve 
the wear resistance of UHMWPE, manufacturers have attempted to increase the cross-
linking density of the polymer [46]. The conventional form is not cross-linked [47]. 
Cross-linking significantly increases the wear abrasion resistance, and reduces the 
mobility of the free radicals [48]. As Table 4 shows the wear rate of conventional 
polyethylene is 6 times more than the highly cross-linked polymer. Experimental data 
showed that cross-linking improves the wear properties of the polymer up to 90\% 
\citep{dum2006, jac2017} (Table \ref{xl} ). Furthermore, a higher abrasion resistance 
in cross-linked polyethylene enables surgeons to use thinner components, which can 
have clinical advantages. For instance, in hip replacement, this allows for the use of a 
larger femoral head; which reduces the risk of dislocation \citep{mur2001}.  
There are three ways of cross-linking polyethylene: radiation, organic peroxide 
chemistry or using saline chemistry \citep{mur2001}. However, only the two first 
methods are clinically approved as saline chemistry is involved the use of harsh 
chemical. 
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In the first two methods, cross-linking is achieved by the formation of active 
sites at the end of the chains. The active sites (free radicals) can recombine to form 
trans-vinylene bonds[49]. Gamma irradiation is the most common way to cross-link 
UHMWPE; however, it also is possible to use electron beam irradiation [48].  Gamma 
irradiation can also be used to sterilise components [50] as discussed in Section 2.8.; the 
peroxide method involves its decomposes by a free radical reaction that leads to the 
formation of cross-links between chains at the elevated temperatures associated with the 
manufacturing process [3].  
Hip simulator study demonstrated approximately 98% reduction in wear at 30 
million cycles when comparing Longevity HXPE with CPE and a 96% reduction in the 
rate of steady-state wear at 2-year follow-up when comparing Longevity HXPE to CPE 
in vivo. 
There are some concerns with both the methods. UHMWPE is semi-crystalline 
and free radicals trapped in crystalline regions are not mobile enough to react with each 
other[49]. However, over time, the free radicals diffuse slowly to the amorphous regions 
and can lead to degenerative oxidation [49]. Similarly, there are concerns about the 
oxidative instability of the peroxide cross-linked version[49]. 
Even though increasing cross-linking density increase the abrasion resistance of 
the polymer, however, the cross-linked polymer is less tolerant to severe clinical 
conditions and less resistance to crack propagation [51,52] . Table 4 shows the 
mechanical properties of conventional and cross-linked polymer, elastic modulus, 
ultimate tensile strength yield strength and ductility of the polymer will be reduced as 
cross-linking density increases. The cross-linking density is increases with radiation and 
100kGy is the saturation point. 
 
 Any alteration in the microstructure of the polymer changes the mechanical 
properties. Cross-linking reduces the plasticity of the polymer which leads to a 32% 
reduction in fracture toughness (Kc).  Fracture toughness determined the fatigue crack 
propagation of the polymer. 
 Retrieval analysis on 4 highly cross-linked acetabular cups showed that there is 
no significant sign of oxidation however brittle fracture failure was the main cause of 
failure in all the samples [52].   
Histological studies have shown cross-linking reduce the biological response to 
the wear particles and a lower amount of multinucleated has been found [49,53].  Fisher 
has shown that cross-linking generates a larger amount of small particles [54]. Larger 
particles cannot be ingested by the macrophages so they will be surrounded 
multinucleated foreign body giant cells, which are the hallmark of a chronic 
inflammatory process. however, the finer particles induce more macrophage and 
inflammatory mediator, resulting in more osteolysis (bone resorption means more bone 
resorption [54]. 
Overall, there is a lower ductility and fatigue resistance associated with 
extensive cross-linking [55]. Furthermore, highly cross-linked UHMWPE has a lower 
toughness and mechanical strength. Therefore, it is desirable to limit the degree of 
cross-linking and keep it local to the surface of the polymer to retain the bulk 
mechanical properties [56]. Oxidation is the main concern with cross-linking. Failure 
analysis of retrieved UHMWPE implants  regularly shows signs of surface cracking, 
abrasion, scratching and pitting marks, which can be due to oxidative degradation 
[51,57]. Hence, different methods have been developed to increase the oxidative 
stability of cross linked UHMWPE, this is covered in next section. 
 Thermal treatment 
As mentioned, free-radicals will be formed during cross-linking or sterilisation 
of UHMWPE, reducing the oxidative stability of the polymer [58,59].  One method 
used to reduce the amount of free radicals is post-irradiation thermal treatment which at 
the same time releases residual stress due the thermal history induced by ram extrusion 
or compression moulding [58]. Two common thermal treatments are re-melting and 
annealing. Re-melting is when the temperature is elevated above the melting point 
(approximately 150° C) leads to complete melting of the polymer crystallites,  allowing 
the free radicals trapped in the crystalline phase to diffuse out [3]. Usually, re-melting 
reduces the amount of residual radicals to undetectable levels.  Annealing is when the 
temperature rise does not exceed the melting point, hence, it leaves a measurable 
amount of free radicals in the polymer [60].Free radicals can be detected from using a 
type of spectroscopy (Electron spin resonance) which is able to detect the unpaired 
electron. There are three types of free radicals alkyl, allyl and polyenyl [61]. 
 The main concern with any thermal treatment is the possibility of reducing 
crystallinity during the cooling process as there is no pressure applied [62]. With current 
processing technologies applying pressure is not feasible [49,63]. The crystallinity of 
UHMWPE is associated with the fatigue crack propagation resistance [64].  
Crystallinity can enhance the oxidative resistance of the polymer. This is because the 
oxygen is only able to diffuse into the amorphous region. Oxidised polymer is more 
brittle and less resistance to fatigue crack propagation [65]. Remelting has been shown 
to significantly reduce the degree of crystallinity [66–69], the crystallinity reduction can 
be as high as 10% [69].  While re-melting determinately effects mechanical properties 
of the polymer, annealing showed no statistically significant decrease in the crystallinity 
(p>0.005) and many of the mechanical properties of the polymer including yield, 
ultimate strength and fatigue properties remain unchanged[3,63]. 
However, results obtained from ageing studies are controversial. Muratoglu and 
co-workers investigated the wear and oxidation properties of remelted and annealed 
cross-linked UHMWPE [61] . As was expected, initially the thermally treated 
UHMWPE had better wear properties than the untreated samples. However, after 
artificial ageing, residual free radicals in annealed samples were detected by Electron 
Spin Resonance (ESR) but not in the remelted samples[61]. Free radicals cause 
oxidation and reduce the ductility and wear resistance of the polymer.  A study of real-
time aged samples also showed a reduction in oxidative stability of annealed UHMWPE 
after ageing [70]. In both studies, a significant oxidation was observed on the surface of 
the UHMWPE test samples.  
 
Many different studies have calculated the linear wear rate of the polymer after 
thermal treatment using hip simulators. There is a broad distribution in wear rates of 
different studies [71–73] , which is likely to be due to variations in design, metallic 
materials and the  size of the femoral head. Nevertheless, all studies demonstrated a 
high reduction in wear rate for the highly cross-linked and annealed UHMWPE, 
compare to untreated UHMWPE.  
The clinical data has detected a measurable amount of oxidation of remelted 
retrieved parts which was significantly higher than in vitro studies. A possible 
explanation could be the test lubricant and the loading conditions of in vitro studies 
[74–77]. It has been proved that UHMWPE is able to absorb the lipid with synovial 
fluid which alters its mechanical properties[74,78,79]. 
 
 To summaries, free radicals were generated during cross-linking and so thermal 
treatment was applied with the intention of reducing the amount of free radicals and 
increasing the oxidative stability of the polymer. The first highly cross-linked 
UHMWPE was irradiated with a high dose followed by melting or annealing. However, 
the material properties of the polymer underwent a significant change after re-melting 
[58]; and annealing did not eliminate all the free radicals [80]. In the second generation, 
high cross-linking levels were achieved by repeating the irradiation and annealing steps 
to allow the free radicals to recombine completely [81]. This method reduced the 
amount of free radical to an undetectable level and ageing studies also showed a very 
low amount of free radicals. However, clinical studies on knee retrievals showed pitting 
and subsurface white banding and cracking [82,83]. Studies hypothesised this was the 
result of lower a crystallinity and fatigue strength. This unsatisfactory result led to a 
search for an alternative to reduce the influence of free radicals, the next section reviews 
use of anti-oxidants to prevent oxidative degradation. 
 
Anti-oxidants 
 
Vitamin E is a natural anti-oxidant, which is able to suppress the free radicals 
which cause oxidation by reducing both alkyl and peroxy radicals, and consequently 
improve the wear resistance of the polymer [84,85]. The addition of vitamin E does not 
require any post-irradiation thermal treatment [86].  
There are two methods of incorporating vitamin E within UHMWPE Figure 2. 
In the first method, vitamin E is blended with UHMWPE prior to consolidations, a 
process that does not affect consolidation, [87], as a free radical scavenger and it can 
inhibit the formation of cross-links. Hence, the vitamin E concentration in the blend 
should be limited to less than 0.3 wt% [88]. The alternative method is diffusion of the 
vitamin into UHMWPE after cross-linking [86], and so cross-linking efficiency is not 
affected. On the other hand, UHMWPE goes through irradiation without any anti-
oxidant protection and an extra homogenisation step is required to obtain an adequate 
concentration of vitamin E throughout the part. Diffusion and homogenisation require 
an elevated temperature to facilitate the diffusion of vitamin E, though the temperature 
is kept below the melting point so it does not effect on the crysrallinity of the polymer 
[87]. 
Overall, in vivo studies have confirmed that vitamin E increases the oxidative 
stability of irradiated UHMWPE so, components are now used clinically [64,86,89–91].  
Knee simulator studies have suggested that vitamin E containing UHMWPE 
(GUR 1050) parts have a lower wear volume compared to the conventional polymer 
parts, suggesting that  anti-oxidants improves the wear resistance. The volumetric wear 
of conventional polymer is 41.3 mm3 and 27  mm^3 for vitamin E added polymer (max 
load 2600 N, 5 million cycles)  [92]. 
 Figure 2 Schematic illustration of the two different methods used to incorporate Vitamin E. The first method involvs 
the diffusion of vitamin E into consolidated and cross-linked UHMWPE parts, the second is blending of the vitamin E 
with the UHMWPE resin prior to consolidation. 
Vitamin E may have an effect on the re-alignment and recrystallisation of the 
polymer chains. The individual polymeric chain stems are able to rotate respect to each 
other, leading to a change in the lamellar structure and also crystals can grow to a larger 
extent  [93]. Okubo et al. have shown that stress induced crystallisation of UHMWPE is 
hindered by the addition of vitamin E. X-ray diffraction results suggested the 
realignment of the molecular chains within the amorphous phase was the cause of these 
changes [94].  
The tensile properties of the vitamin E infused polyethylene changed, 10% 
increase in yield strength and 12% drops in ultimate tensile strength of the polymer 
[95]. There was a 25% increase in fatigue crack propagation of the polymer [95]. A 
possible explanation is that Vitamin E can be a plasticising agent and lead to an increase 
in the chain mobility which can be the reason for the improved fatigue strength [93]. 
 
The mechanical and fatigue strength of vitamin E infused polyethylene is greater 
than the highly cross-linked UHMWPE [89], and there was no significant difference 
between the mechanical properties of vitamin E treated and untreated samples. vitamin 
E diffused UHMWPE led to no significant alteration in the stress intensity factor of the 
polymer after artificial ageing, equivalent to 5 years of natural ageing [64,96]. Stress 
intensity factor indicates the fatigue crack propagation of the polymer. This can be 
because one method that materials decrease the localised stress at the crack tip is by 
plastic deformation. Vitamin E can act as a plasticizing agent and increase the ductility 
and chain mobility of the polymer. Furthermore as there is no thermal treatment (re-
melting or annealing) after adding vitamin E hence the crystallinity of the polymer is 
going to be intact preserving the mechanical properties of the polymer. 
Animal and cell studies did not detect any adverse biological response to 
vitamin E infused part, and clinical data to date support the in-vitro results. Hence, it 
can be concluded, vitamin E-stabilisation is a promising alternative to thermal 
treatments  [97]. 
Vitamin UHMWPE was clinically introduced in 2007, and short term clinical 
data ( up to 3 years) shows that there is no specific complication with this type of 
polymer and there is no significant difference in the wear rate of UHMWPE and highly 
cross-linked polymer [98]. Clinical data to date support there are no negative short term 
complications with this material and low concentration of free radicals can be indication 
of long term oxidative stability.  However, there is no information available regarding 
the performance of the parts beyond 10 years.  
 
 
Packaging and sterilisation 
 
 
Finished UHMWPE components need to undergo packaging and sterilisation 
before clinical use. Figure 3 shows the current packing methods used.  
 
Figure 3 There are three different type of packaging for an UHMWPE part including gas permeable, multi-layer film 
barrier packaging and barrier packaging., 
The most common way to sterilise UHMWPE is high energy radiation [99]. 
Typically, a nominal dose of 25 to 40 kGy gamma sterilisation is used [100]. As 
mentioned previously, cross-linking can be formed using irradiation and the main 
concern was that a high dose of radiation in air promotes oxidative degradation and loss 
of desirable properties [101]. To avoid any oxidation, manufacturers perform the 
irradiation in a vacuum or under an inert gas such as nitrogen or argon [102]. Since 
there is no oxygen available, the free radicals will recombine and form UHMWPE 
cross-links rather than oxidise the UHMWPE.  
Another method of sterilisation is ethylene oxide sterilisation (EtO). EtO has a 
high toxicity and is able to neutralise bacteria, spores and viruses. EtO can be used for 
UHMWPE parts as there are no constituents which are able to react or bind to the toxic 
gas. Therefore, EtO has no substantial influence on the mechanical, physical and 
mechanical properties of the polymer [103,104]. Sterilisation of UHMWPE is achieved 
by diffusion of EtO into near surface regions (up to 2 mm depth), then allowing it to 
diffuse out [75]. It is important that all ethylene diffuses out of the polymer as it can be 
toxic for biological tissues.  Studies on retrieved implants have shown that EtO 
sterilised UHMWPE ex-plants have a less surface damage and delamination compared 
to those which underwent gamma sterilisation [105].  
The third possible method of sterilisation is   gas plasma, a surface sterilization 
method that relies upon ionized gas for deactivation of biological organisms [99].  
Either low-temperature peracetic acid gas plasma or low-temperature hydrogen 
peroxide gas plasma can be used. Many different studies show that gas plasma has no 
effect on the mechanical, chemical and physical properties of the polymer [106–109]; 
however, it has been shown that the mechanical properties of porous UHMWPE and 
UHMWPE fibre can change as it goes through GP. Studies have hypothesised this is 
because gas plasma reacts with the surface of the polymer, and porous or fibrous 
UHMWPE have a higher surface area [104]. The main advantage of gas plasma is that it 
does not leave any toxic residue in the polymer and does not create free radicals.   
Different manufacturing procedures tend to use different methods of sterilisation 
and none of these options can be considered as the preferred method. All these methods 
have some disadvantages; radiations create free-radicals, while there is a possibility that 
EtO leave toxic residues within the UHMWPE however to the date of this study there is 
no case of toxicity. Finally GP might modify the surface chemistry of the polymer 
[104].  
Packaging is important, as the UHMWPE components are usually stored prior to 
implantation. There are three clinically approved classes of packaging, including gas 
permeable packaging (class I), multi-layer film barrier packaging (class II) and barrier 
packaging (class III). All the manufactured at entitled to show an expiration date on the 
packaging}. {The main difference between the types of packing is the polymers used in 
the packages. The polymeric materials of each type of packaging has been explained in 
Figue 3.  
  
 A study by Costa et al examined the oxidation level of the parts packed using 
one of the three classes [110]. The oxidation index was calculated based on American 
society for Testing and Materials (ASTM). According to the standard the oxidation 
index of the parts should be less than 1 to be suitable for clinical application. Prior to 
the expiry date the oxidation index of the parts in all three different type of packaging 
were less than 0.5 and there was no statistically significant difference between the 
values of the oxidation index of different groups (p < 0.05 for Mann-Whitney tests). On 
the other hand, significant oxidation was associated with class I and II expired 
packaging but not class III [110]. 
Overall, all three types of packaging meet ASTM requirements and none of 
them causes a significant alteration in the chemistry of the polymer unless the 
packaging is expired.  
Radiopaque UHMWPE 
 
At the time of this study, there was no commercially available bulk radiopaque 
UHMWPE. However, Bogie et al. used bismuth trioxide to develop a novel radiopaque 
UHMWPE fibres [18] for an application in a growth-guidance system for early-onset 
scoliosis. In this study 20 wt%,   Bi2O3 particles were blended  into each UHMWPE 
fibre [18]. This polymer is available on the market under the commercial name of 
Dyneema. 
 
 
However, this product is relatively new and there are not many publications 
examining the effect of Bi2O3 on the mechanical properties of the UHMWPE.  Bogie et 
al referred to unpublished data which confirmed all the samples containing Bi2O3 
survived the fatigue test (N=5 million cycles, F=1350 N) [18].  
Recently, Roth et al. studied the effect of the addition of Bi2O3 on the fatigue 
and tensile properties of UHMWPE woven cables [111]. Their study suggested that the 
tensile and fatigue strength of the UHMWPE were not deleteriously affected by the 
addition of Bi2O3 particles. Contrary to expectations, a leaching study did not find a 
detectable release of Bi2O3 in the in vitro environment [111]; however, the animal 
testing detected particles of Bi2O3 in different tissues [18]. One possible explanation for 
this difference is that in this study the samples were not loaded, and furthermore, the 
saline solution used does not accurately represent the in vivo environment [112].  
 
There are no clinical studies are available with regard to the radiopaque 
UHMWPE fibre. Histological studies on the surrounding tissues of the animals showed 
no chronic inflammation to the radio-pacifying agent [18],  
  
In a different study Kozakiewicz et al. attempted to make a radiopaque 
UHMWPE using TiO2 [113]. Their experimental data suggested that some of the 
mechanical properties of the polymer including hardness, tensile modulus and strength 
of modulus of the polymer decreased. Also, even though a slight radiological detection 
was possible, the radiopacity of this polymer was not comparable with metals.   
A few patents have disclosed methods to create radiopaque UHMWPE 
[114,115]. One of them suggested combining UHMWPE with oil-based fluids 
containing heavy elements such as iodine [114]. Another patent by US researchers used 
an ion plasma deposition coating to make UHMWPE visible in X-ray images [116]. 
One of the limitations with the use of a coating is its adhesion strength to the main 
component, though this is an interesting approach which could have potential for further 
research.  
 
 Critique and Research Gaps 
 
UHMWPE is the bearing material for most of the orthopaedic replacements. The 
polymer has a limited radiopacity wear resistance and antimicrobial properties which if 
improved, could enhanced the longevity of the implant.  
 
One of the limitations with UHMWPE components is lack of radiopacity. 
Therefore, early diagnosis of failure can be hard and it is not possible to monitor the 
implant positioning during the surgery. Currently, there is no clinically approved 
radiopaque UHMWPE which can be used for bulk surgical implants. The only 
radiopaque UHMWPE is a fibre and the technology cannot be used manufacture 
UHMWPE components. Therefore, enhancing the radiopacity of the polymer could 
have significant clinical benefits. One way to enhance the radiopacity of the polymer is 
by introducing a group like iodine which has a high radiopacity. As this review covered, 
vitamin E is an oil-based fluid which has been used to increase the oxidative stability of 
the polymer. Vitamin E had no detrimental effect on the mechanical properties of the 
polymer. It can be hypothesised that other oil-based fluids are also able to diffuse into 
the polymer. Lipiodol is another oil-based fluid with similar properties to vitamin E and 
the fluid contains iodine, so it is radiopaque. Lipiodol can be diffused into the polymer 
and enhance the X-ray attenuation of the part [114]. 
 Wear of the UHMWPE bearing is the major cause of failure and a key 
limitation. Hence, many researchers have attempted to enhance the wear resistance of 
the polymer to reduce the production of wear particles and enable implants to have 
greater longevities. Introducing cross-linking and vitamin E to the polymer, using 
thermal treatment are ways of enhancing the wear resistance. However, wear is still a 
common cause of failure. A few patents have been disclosed which aim to enhance the 
wear resistance of UHMWPE parts. One of them suggested the polymer resin can be 
irradiated prior to consolidation to have a better control on the radiation and achieving a 
higher degree of cross-linking [117]. A possible complication is that a high degree of 
cross-linking reduces to the ductility of the part, hence it is preferable to limit the cross-
linking to the surface of the polymer not the bulk. Another possible challenge in this 
method is that radiation may enhance the rate of oxidation due to the formation of free 
radicals. Although most of the time the part will be stored in a non-oxidative 
environment, oxidation can occur in vivo and is increased by certain macromolecules in 
the synovial fluid such as Squalene [118]. The feasibility of running the consolidation 
and manufacturing process in an inert environment is low. 
Another patent suggested that the use of sequential irradiation and followed by 
sequential annealing is able to reduce the oxidation and enhance the wear resistance 
[119]. This is because each radiation can be low while the total dose of irradiation is 
sufficient enough to achieve a high degree of cross-linking. A possible limitation of this 
method is controlling the location of the cross-linking. To retain the mechanical 
properties of the polymer, cross-linking should be limited to the surface of the polymer. 
Micro-injection moulding attempted to be used to control physical and chemical 
properties of the polymer and enhance the wear resistance [120]. Due to the high 
molecular weight of the polymer, this method can be very expensive.  
Most of the methods that enhance the wear resistance of the polymer may lead 
to the reduction of some other mechanical properties of the polymer. The fatigue crack 
propagation resistance of cross-linked UHMWPE is approximately %40 lower than the 
none cross-linked polymer [55,96]. This is a source of concern, especially where the 
implant is subjected to a high stress. Hence there should be a way to enhance the fatigue 
resistance of the polymer without jeopardizing the wear resistance. Currently, 
manufacturers try to limit cross-linking to the articulating surface, so the mechanical 
properties of the bulk stay intact. This method is not feasible for curved surfaces. A 
study by Oral et al. attempted to manipulate the degree of cross-linking by using a 
spatially variant concentration profile of vitamin E during irradiation [121]. The surface 
of the polymer has a lower concentration of vitamin E than the bulk and their 
experimental data was promising. Using materials with a higher fatigue resistance can 
be very beneficial as it means a thinner part can be used. Using thin parts means 
surgeons would be able to preserve a higher amount of the bone stock and reduce the 
chance of dislocation [121]. 
Bacterial infection is a post-operative complication and one of the main cause of 
early failure [122,123]. Around 4000 to 8000 infected knee implants requiring surgical 
revision annually [124]. Due to lack of blood supply around the implant, it can be hard 
to deliver a drug to the site of surgery. Localised drugs and antibiotics are normally 
used after the surgery. This means patients will be exposed to a high dose of drugs 
which can be dangerous [125]. Furthermore, this is not a long term solution.  Hence, 
making an implant with sustained antimicrobial ability can be very beneficial. So a few 
studies have attempted to use UHMWPE as a drug delivery device [126,127]. A study 
by Kumar et al. attempt to coat the inner surface of with some drug loaded 
biodegradable polymer [126] , so as the polymer wear off drugs will be realised to the 
site of surgery. In this case, retaining the tribological and mechanical properties of the 
polymer can be very challenging. Muratoglu et al, tried to mould UHMWPE with 
vancomycin which is an antibiotic; their results showed that the present of the drug 
reduced the ultimate strength and the impact toughness of the polymer. Antimicrobial 
properties of UHMWPE can also be enhanced using ion implantation. The experimental 
results showed that the bacterial adhesion reduces up to 90% depending on type of the 
ion [128].  There is no published information available with regards to alteration in the 
mechanical properties of this type of resin polymer.   
 
This section attempted to cover the gaps of research and how UHMWPE can be 
modified to enhance. The mobility and quality of life for the patients. Radiological 
limitation of UHMWPE led to difficulty in implant positioning and post-operative 
follow-up. Wear resistance and fatigue propagation of the polymer should be improved 
and anti-microbial UHMWPE can reduce the risk of revision surgery.  
Conclusion 
 As Figure 4 shows the number orthopaedic procedure increases every year. 
Therefore, this paper has reviewed and explained the clinical applications of 
UHMWPE, how polyethylene implants are manufactured and the concerns associated 
with them in orthopaedic replacement. 
Ultra-high molecular polyethylene is the material of choice for the orthopaedics 
bearing materials. The experimental data showed that the polymer has a friction of 
approximately 0.5, however, polymer wear properties are limited and the resistance to 
wear decreases with time. A possible explanation is oxidation caused by free radicals. 
Oxygen is able to diffuse through the polymer even very slowly. Oxidation causes 
breakage of the polymer chains, making the polymer less ductile. Plastic deformation of 
the polymer is a way that polymer resists the fracture crack propagation. Therefore, as 
the ductility decreases, the polymer resistance to crack decreases. 
 
Another common cause of failure is wear and researchers have attempted to 
enhance the wear properties of the polymer, which can be achieved by introducing the 
cross-linking. Depending on the amount of cross-linking, the wear resistance of the 
polymer can be enhanced by 90% however cross-linking will reduce the resistance of 
the polymer to crack propagation and fatigue. The radiation dose of 50-100 kGy is 
required for cross-linking. Also free radicals are required to form cross-links. If there is 
a free radical trapped inside the crystalline areas of polymer, over the time it can react 
with oxygen and cause oxidation.  
Thermal treatment was introduced to reduce the amount of the free radicals 
inside the polymer. Post-irradiation melting leads to the reduction in the crystallinity 
which reduces the other properties of the polymer.  
Alternative approaches have been developed to enhance the polymer oxidation 
and wear resistance. One them is incorporating vitamin E, experimental and clinical 
data so far suggested that there is no short term complication. Vitamin E was clinically 
introduced on 2007 and there is no long term information available. 
Even though wear and oxidation reduced significantly since the first generation 
of bearing, they are still cause major concern. Radiopacity of the polymer can be 
enhanced to improve the wear analysis of the implants as well as diagnose early failure. 
 Figure 4. The number of hip and knee replacements in England and Wales 
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